COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation
- DOI
- 10.1186/s12920-026-02446-y
- Published
- 2026-08-05
- Container
- BMC Medical Genomics
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12920-026-02446-y,
title = {COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation},
author = {Shiyu Yang and Xia Lin and Wen Liu and Xiwei Hu},
year = {2026},
journal = {BMC Medical Genomics},
doi = {10.1186/s12920-026-02446-y},
url = {https://doi.org/10.1186/s12920-026-02446-y}
}RIS
TY - JOUR TI - COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation AU - Shiyu Yang AU - Xia Lin AU - Wen Liu AU - Xiwei Hu PY - 2026 JO - BMC Medical Genomics DO - 10.1186/s12920-026-02446-y UR - https://doi.org/10.1186/s12920-026-02446-y ER -
APA
Yang, S., Lin, X., Liu, W., & Hu, X. (2026). COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation. BMC Medical Genomics. https://doi.org/10.1186/s12920-026-02446-y
Source records
- crossref · retrieved 2026-11-04T18:44:04.202Z